Market Shrugs Off This Drugmaker’s Turnaround
This drugmaker achieved a milestone – its first quarterly profit. But the stock is down despite the good tidings. read more
This drugmaker achieved a milestone – its first quarterly profit. But the stock is down despite the good tidings. read more
Oil prices saw a considerable drop on Thursday. This decline is attributed to the potential U.S.-Iran nuclear deal and a sudden increase in U.S. crude oil inventories, triggering concerns of oversupply. read more
U.S. stock futures were lower on Thursday after a mixed close on Wednesday. Futures of benchmark indices were trading lower in premarket. read more
This cash-strapped company is shifting from its roots in cancer drug development to focus on cosmetic treatments. read more
Performance marketing platform, Ibotta Inc., offers fresh insights into changing brand behaviors, particularly the strategies adopted by consumer packaged goods (CPG) companies to navigate today’s highly competitive retail environment. read more
Ethereum was trading lower early Thursday, reversing a searing rally that made it the most successful large-cap coin over the week. What happened: The second-largest cryptocurrency by market capitalization fell below $2,600 on profit-taking, having reclaimed $2,700 the day before. The trading volume dropped 34% in the last 24 hours. read more
Senate Dems demand probe into Trump admin’s potential aid to Elon Musk’s SpaceX in foreign markets. read more
Networking and communications giant Cisco Systems Inc. is laying the groundwork to upend a core pillar of enterprise cybersecurity, that is, the humble firewall. read more
In a major move towards international expansion, Baidu Inc. (NASDAQ: BIDU) is reportedly preparing to test its autonomous ride-hailing service in Europe. read more